Anika Therapeutics
ANIK
Anika Therapeutics (ANIK) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| B. Riley Securities | Maintained | Buy | $21.00 from $18.00 | Jul 30, 2026 |
| Barrington Research | Maintained | Outperform | $17.00 from $16.00 | Feb 27, 2026 |
| Barrington Research | Maintained | Outperform | $16.00 | Jan 9, 2026 |
| Barrington Research | Maintained | Outperform | $16.00 from $15.00 | Nov 6, 2025 |
| Barrington Research | Maintained | Outperform | $15.00 | Sep 23, 2025 |
| Barrington Research | Maintained | Outperform | $15.00 from $19.00 | Jul 31, 2025 |
| Barrington Research | Maintained | Outperform | $19.00 from $20.00 | May 12, 2025 |
| Barrington Research | Maintained | Outperform | $20.00 from $25.00 | Mar 13, 2025 |
| Barrington Research | Maintained | Outperform | $25.00 from $37.00 | Nov 1, 2024 |
| Barrington Research | Maintained | Outperform | $37.00 | Oct 22, 2024 |
| Barrington Research | Maintained | Outperform | $37.00 | Aug 9, 2024 |
| Stephens & Co. | Maintained | Equal-Weight | $24.00 | May 29, 2024 |
| Barrington Research | Maintained | Outperform | $37.00 | May 9, 2024 |
| Stephens & Co. | Maintained | Equal-Weight | $22.00 | Mar 14, 2024 |
| Barrington Research | Maintained | Outperform | $37.00 from $29.00 | Mar 14, 2024 |
| Barrington Research | Maintained | Outperform | $29.00 from $28.00 | Jan 3, 2024 |
| Barrington Research | Maintained | Outperform | $28.00 from $24.00 | Nov 3, 2023 |
| Barrington Research | Upgraded | Market Perform → Outperform | $24.00 | Aug 14, 2023 |
| Stephens & Co. | Maintained | Equal-Weight | $23.00 from $28.00 | Aug 10, 2023 |
| Stephens & Co. | Maintained | Equal-Weight | $28.00 | May 31, 2023 |
Frequently asked questions
What is the latest analyst rating on ANIK?
On Jul 30, 2026, B. Riley Securities maintained Anika Therapeutics at Buy with a price target of $21.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.